Madrigal Pharmaceuticals Inc (MDGL) Price Prediction & ForecastMDGLMadrigal Pharmaceuticals Inc

Alphio's MDGL stock price prediction model matches the current Madrigal Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $538.88 (+0.96%). The 1-week path is $536.38 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Madrigal Pharmaceuticals Inc is a good buy right now due to its strong sales growth momentum, with Rezdiffra achieving $364.3 million in Q2 sales, reflecting a 71% year-over-year increase. Additionally, the current price of $533.76 is significantly below the analyst price targets, which range from $605 to $962, indicating substantial upside potential. The main risk is the forward P/E ratio of 666.67, suggesting high expectations that may not be met if growth slows.

Madrigal Pharmaceuticals Inc (MDGL) last closed at $533.76, losing -1.83%. These facts feed the 1-day and 1-week MDGL price prediction above.